Literature DB >> 24531488

Adherence to Bürgi-Dunitz stereochemical principles requires significant structural rearrangements in Schiff-base formation: insights from transaldolase complexes.

Samuel H Light1, George Minasov1, Mark-Eugene Duban1, Wayne F Anderson1.   

Abstract

The Bürgi-Dunitz angle (αBD) describes the trajectory of approach of a nucleophile to an electrophile. The adoption of a stereoelectronically favorable αBD can necessitate significant reactive-group repositioning over the course of bond formation. In the context of enzyme catalysis, interactions with the protein constrain substrate rotation, which could necessitate structural transformations during bond formation. To probe this theoretical framework vis-à-vis biocatalysis, Schiff-base formation was analysed in Francisella tularensis transaldolase (TAL). Crystal structures of wild-type and Lys→Met mutant TAL in covalent and noncovalent complexes with fructose 6-phosphate and sedoheptulose 7-phosphate clarify the mechanism of catalysis and reveal that substrate keto moieties undergo significant conformational changes during Schiff-base formation. Structural changes compelled by the trajectory considerations discussed here bear relevance to bond formation in a variety of constrained enzymic/engineered systems and can inform the design of covalent therapeutics.

Entities:  

Keywords:  Bürgi–Dunitz angle; Schiff bases; imines; induced fit; nucleophiles; pentose phosphate pathway

Mesh:

Substances:

Year:  2014        PMID: 24531488      PMCID: PMC3940192          DOI: 10.1107/S1399004713030666

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  21 in total

1.  Crystal structure of decameric fructose-6-phosphate aldolase from Escherichia coli reveals inter-subunit helix swapping as a structural basis for assembly differences in the transaldolase family.

Authors:  Stina Thorell; Melanie Schürmann; Georg A Sprenger; Gunter Schneider
Journal:  J Mol Biol       Date:  2002-05-24       Impact factor: 5.469

2.  Coot: model-building tools for molecular graphics.

Authors:  Paul Emsley; Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

3.  LigPlot+: multiple ligand-protein interaction diagrams for drug discovery.

Authors:  Roman A Laskowski; Mark B Swindells
Journal:  J Chem Inf Model       Date:  2011-10-05       Impact factor: 4.956

4.  Product binding and role of the C-terminal region in class I D-fructose 1,6-bisphosphate aldolase.

Authors:  N Blom; J Sygusch
Journal:  Nat Struct Biol       Date:  1997-01

5.  Novel phosphotransferase system genes revealed by bacterial genome analysis--a gene cluster encoding a unique Enzyme I and the proteins of a fructose-like permease system.

Authors:  J Reizer; A Reizer; M H Saier
Journal:  Microbiology       Date:  1995-04       Impact factor: 2.777

6.  Identification of catalytically important residues in the active site of Escherichia coli transaldolase.

Authors:  U Schörken; S Thorell; M Schürmann; J Jia; G A Sprenger; G Schneider
Journal:  Eur J Biochem       Date:  2001-04

7.  The three-dimensional structure of human transaldolase.

Authors:  S Thorell; P Gergely; K Banki; A Perl; G Schneider
Journal:  FEBS Lett       Date:  2000-06-23       Impact factor: 4.124

8.  Crystal structure of transaldolase B from Escherichia coli suggests a circular permutation of the alpha/beta barrel within the class I aldolase family.

Authors:  J Jia; W Huang; U Schörken; H Sahm; G A Sprenger; Y Lindqvist; G Schneider
Journal:  Structure       Date:  1996-06-15       Impact factor: 5.006

9.  Lysine144 is essential for the catalytic activity of Saccharomyces cerevisiae transaldolase.

Authors:  T Miosga; I Schaaff-Gerstenschlager; E Franken; F K Zimmermann
Journal:  Yeast       Date:  1993-11       Impact factor: 3.239

10.  Inhibition of the catalytic activity of human transaldolase by antibodies and site-directed mutagenesis.

Authors:  K Banki; A Perl
Journal:  FEBS Lett       Date:  1996-01-08       Impact factor: 4.124

View more
  8 in total

1.  Arabinose 5-phosphate covalently inhibits transaldolase.

Authors:  Samuel H Light; Wayne F Anderson
Journal:  J Struct Funct Genomics       Date:  2014-02-09

2.  Isomer activation controls stereospecificity of class I fructose-1,6-bisphosphate aldolases.

Authors:  Paul W Heron; Jurgen Sygusch
Journal:  J Biol Chem       Date:  2017-09-27       Impact factor: 5.157

3.  Kinetic Optimization of Lysine-Targeting Covalent Inhibitors of HSP72.

Authors:  Jonathan Pettinger; Michael Carter; Keith Jones; Matthew D Cheeseman
Journal:  J Med Chem       Date:  2019-12-06       Impact factor: 7.446

4.  Crystal structures of type I dehydroquinate dehydratase in complex with quinate and shikimate suggest a novel mechanism of Schiff base formation.

Authors:  Samuel H Light; Aleksandar Antanasijevic; Sankar N Krishna; Michael Caffrey; Wayne F Anderson; Arnon Lavie
Journal:  Biochemistry       Date:  2014-01-31       Impact factor: 3.162

5.  Biosynthesis of dendroketose from different carbon sources using in vitro and in vivo metabolic engineering strategies.

Authors:  Jiangang Yang; Yueming Zhu; Ge Qu; Yan Zeng; Chaoyu Tian; Caixia Dong; Yan Men; Longhai Dai; Zhoutong Sun; Yuanxia Sun; Yanhe Ma
Journal:  Biotechnol Biofuels       Date:  2018-10-25       Impact factor: 6.040

6.  VALD-3, a Schiff base ligand synthesized from o-vanillin derivatives, induces cell cycle arrest and apoptosis in breast cancer cells by inhibiting the Wnt/β-catenin pathway.

Authors:  Hongling Li; Chunyan Dang; Xiaohui Tai; Li Xue; Yuna Meng; Shuping Ma; Jing Zhang
Journal:  Sci Rep       Date:  2021-07-22       Impact factor: 4.379

7.  Anti-Electrostatic Pi-Hole Bonding: How Covalency Conquers Coulombics.

Authors:  Frank Weinhold
Journal:  Molecules       Date:  2022-01-07       Impact factor: 4.411

8.  An enzymatic activation of formaldehyde for nucleotide methylation.

Authors:  Charles Bou-Nader; Frederick W Stull; Ludovic Pecqueur; Philippe Simon; Vincent Guérineau; Antoine Royant; Marc Fontecave; Murielle Lombard; Bruce A Palfey; Djemel Hamdane
Journal:  Nat Commun       Date:  2021-07-27       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.